Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACRoss-AMI: Nifedipine vs Benidipine After Acute Myocardial Infarction
jRCTs071180056Completed
- Sponsor
- Bayer
- Start
- Aug 2013
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of nifedipine and benidipine in myocardial infarction (MI), Coronary vasospasm (CAS) and Coronary endothelial dysfunction (CED) (4 arms), sponsored by Bayer. Primary endpoint: Change in ACh-provoked coronary constrictive response and coronary vascular tone. Started Aug 2013; status: completed.
02
Drugs
nifedipinebenidipine
03
Conditions
myocardial infarction (MI)Coronary vasospasm (CAS)Coronary endothelial dysfunction (CED)
Beyond the preview
Go deeper on jRCTs071180056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180056.